March 5, 2008
Discovery of Januvia™ (sitagliptin), a Selective Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 DiabetesAnn E. Weber, PhD Executive Director, Medicinal Chemistry Merck Research Laboratorie For more information, please contact:
A. K. Ganguly Distinguished Research Professor of Chemistry; Associate Director for Research McLean Room 316 Phone: 201.216.5540 Fax: 201.216.8240 aganguly@stevens.edu |